Symptoms management of advanced lung disease

V. Carrieri-Kohlman (San Francisco, United States Of America)

Source: Annual Congress 2004 - Palliative care in lung disease
Session: Palliative care in lung disease
Session type: Assembly Symposium
Number: 2862
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Carrieri-Kohlman (San Francisco, United States Of America). Symptoms management of advanced lung disease. Annual Congress 2004 - Palliative care in lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The management of GERD in patients with advanced lung disease: drugs or surgery?
Source: Annual Congress 2009 - The role of gastro-oesophageal reflux in advanced lung disease
Year: 2009

Impact of COVID-19 on patients with chronic lung disease
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Transition from treatment to palliation in chronic lung disease
Source: Annual Congress 2006 - PG10 - Preparation and palliation for end-of-life in chronic respiratory disease
Year: 2006

Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016

Coexistence of chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer and impact on survival
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Challenging infections in advanced CF lung disease
Source: Annual Congress 2013 –Challenges in lung transplantation for cystic fibrosis
Year: 2013


Challenges in molecular testing in lung cancer patients with advanced disease
Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Year: 2016


Dyspnoea management in end-stage lung disease
Source: Annual Congress 2006 - Improving end-of-life care
Year: 2006


Impact of chronic obstructive pulmonary disease on the recurrence and second tumors of lung cancer after surgical resection
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019



Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Association of caregiver burden and depression in caregivers of patients with chronic respiratory failure secondary to advanced and end stage lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Role of surgical management in oligometastatic disease
Source: International Congress 2019 – New perspectives in thoracic surgical oncology
Year: 2019


Chronic obstructive pulmonary disease as a predictor of lung cancer mortality
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Pulmonary function evaluation in advanced Parkinson‘s disease
Source: Eur Respir J 2006; 28: Suppl. 50, 201s
Year: 2006

Delay in diagnosis of COPD leading to poor prognosis of disease
Source: International Congress 2015 – Different data in COPD
Year: 2015


Psychological outcomes from pulmonary rehabilitation in patients with chronic obstructive lung disease
Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more?
Year: 2010

Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021